Literature DB >> 20833453

Crystal structures, DNA-binding and cytotoxic activities studies of Cu(II) complexes with 2-oxo-quinoline-3-carbaldehyde Schiff-bases.

Zeng-Chen Liu1, Bao-Dui Wang, Bo Li, Qin Wang, Zheng-Yin Yang, Tian-Rong Li, Yong Li.   

Abstract

Three novel 2-oxo-quinoline-3-carbaldehyde Schiff-bases and their Cu(II) complexes were synthesized. The molecular structures of Cu(II) complexes were determined by X-ray crystal diffraction. The DNA-binding modes of the complexes were also investigated by UV-vis absorption spectrum, fluorescence spectrum, viscosity measurement and EB-DNA displacement experiment. The experimental evidences indicated that the ligands and Cu(II) complexes could interact with CT-DNA (calf-thymus DNA) through intercalation, respectively. Comparative cytotoxic activities of ligands and Cu(II) complexes were also determined by MTT [3-(4,5-dimethyl-2-thiazoyl)-2,5-diphenyl-2H-tetrazolium bromide] and SRB (sulforhodamine B) methods. The results showed that the three Cu(II) complexes exhibited more effective cytotoxic activity against HL60 cells and HeLa cells than corresponding ligands. Also, CuL(3) showed higher cytotoxic activity than CuL(1) and CuL(2).
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20833453     DOI: 10.1016/j.ejmech.2010.08.060

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  8 in total

1.  Structure-activity relationship study of copper(II) complexes with 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (4'-methylbenzoyl) hydrazone: synthesis, structures, DNA and protein interaction studies, antioxidative and cytotoxic activity.

Authors:  Duraisamy Senthil Raja; Nattamai S P Bhuvanesh; Karuppannan Natarajan
Journal:  J Biol Inorg Chem       Date:  2011-09-20       Impact factor: 3.358

2.  Synthesis of Ni(II) complexes bearing indole-based thiosemicarbazone ligands for interaction with biomolecules and some biological applications.

Authors:  Jebiti Haribabu; Kumaramangalam Jeyalakshmi; Yuvaraj Arun; Nattamai S P Bhuvanesh; Paramasivan Thirumalai Perumal; Ramasamy Karvembu
Journal:  J Biol Inorg Chem       Date:  2016-12-19       Impact factor: 3.358

3.  Copper(II) and oxidovanadium(IV) complexes of chromone Schiff bases as potential anticancer agents.

Authors:  Patrique Nunes; Yasemin Yildizhan; Zelal Adiguzel; Fernanda Marques; João Costa Pessoa; Ceyda Acilan; Isabel Correia
Journal:  J Biol Inorg Chem       Date:  2021-11-24       Impact factor: 3.358

4.  Pd(ii) and Pt(ii) complexes of tridentate ligands with selective toxicity against Cryptococcus neoformans and Candida albicans.

Authors:  Ahmed M Mansour
Journal:  RSC Adv       Date:  2021-12-14       Impact factor: 4.036

5.  Luminescent Behavior of Ru(II) Polypyridyl Morpholine Complexes, Synthesis, Characterization, DNA, Protein Binding, Sensor Effect of Ions/Solvents and Docking Studies.

Authors:  Ravi Kumar Vuradi; Venkat Reddy Putta; Deepika Nancherla; Satyanarayana Sirasani
Journal:  J Fluoresc       Date:  2015-12-26       Impact factor: 2.217

6.  Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition.

Authors:  Amany M Ghanim; Samar Rezq; Tarek S Ibrahim; Damian G Romero; Hend Kothayer
Journal:  Eur J Med Chem       Date:  2021-04-20       Impact factor: 7.088

Review 7.  Heterocyclic Schiff base transition metal complexes in antimicrobial and anticancer chemotherapy.

Authors:  Manzoor Ahmad Malik; Ovas Ahmad Dar; Parveez Gull; Mohmmad Younus Wani; Athar Adil Hashmi
Journal:  Medchemcomm       Date:  2017-12-06       Impact factor: 3.597

8.  New Potential Antimalarial Agents: Design, Synthesis and Biological Evaluation of Some Novel Quinoline Derivatives as Antimalarial Agents.

Authors:  Ibrahim Ali M Radini; Tarek M Y Elsheikh; Emad M El-Telbani; Rizk E Khidre
Journal:  Molecules       Date:  2016-07-14       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.